Patent · US Expired

Method of treating or inhibiting obesity

US7238470B2 · kind B2 · utility

8Cited by

2References

3Claims

0Family size

Assignee

Solvay Pharmaceuticals, GmbH · US

Inventors

Johannes Hebebrand · Marburg, DE
Jochen Antel · Annaberg-Buchholz, DE
Ulf Preuschoff · Laatzen, DE
Samuel David · Dorval, CA
Holger Sann · Hannover, DE
Michael Weske · Burgdorf, DE

Key dates

Filing date	Feb 25, 2004
Grant date	Jul 3, 2007
Priority date	—
Expiry date	Mar 6, 2024

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/044
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for the discovery of compounds suitable for the treatment and/or prophylaxis of obesity, in which the ability of the test compounds to inhibit de novo lipogenesis in mammals and/or man is determined. The use of compounds which are capable of inhibiting de novo lipogenesis in mammals, and which are substantially free of effects directed towards the CNS, for the preparation of pharmaceutical compositions for the treatment and/or prophylaxis of obesity, as well as for the treatment and/or inhibition of obesity, are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.